No Detail Found!

Blood Levels of micoRNA-21 in Newly Diagnosed Patients With Type 2 Diabetes Mellitus in Iraqi Population

Author(s)
Huda B. Al-Lami Department of Chemistry and Biochemistry, Faculty of Medicine, University of Maysan; Department of Biochemistry, Faculty of Medicine, University of Kerbala.
Ouahchi Ines Department of Chemistry and Biochemistry Faculty of Medicine University of Soussa.
Ammar Gany Yassin Department of Biochemistry, Faculty of Medicine, University of Kerbala.
Abstract
Diabetes mellitus (DM) is now regard as a worldwide health issue affecting hundreds millions of people. It is a metabolic disease targeting glucose metabolism and insulin homeostasis, Type 2 diabetes mellitus (T2DM) is the most prevent type of this disease accounting about 90-95% of the disease as whole. microRNAs (miRNAs) which are a small non-coding RNAs, they revolutionized as potential new biomarkers for the diagnosis and prognosis of a wide range of disorders. Recent studies prove the relationship between miR-21 and inflammatory process and insulin resistance, our emphasis suggest there is a role of miR-21 in insulin resistance in T2DM. Studies have explored the potential of miR-21 as diagnostic biomarkers for T2DM. The purpose of this study is to compare the sera levels of miRNA-21 among newly diagnosed patients e with T2DM patients with their levels in apparently healthy subjects using blood samples. The time frame for this case-control research is August 2022 through March 2023, and it took place at Al-Sadr Teaching Hospital/ Masin / Iraq. There were 100 patients home recent diagnosed with T2DM (50 females and 50 males) with age ranged between (20 -70 years) and 100 apparently healthy subject who dealt with as control group. 2 ml of blood drown from each patient and healthy person, putted it in EDTA tube with 1 ml of Trizole as a preservative, and put the tubes in the freezer at -70 degrees Celsius until analyze the samples.
Publication Details
Page(s) 157-159
Published Journal: Journal of Pioneering Medical Sciences, Volume: 13, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Diabetes mellitus, Diabetes mellitus, Insulin, T2DM, miR-21
References
Wang S.,Yang Z.,Gao Y.,Li Q.,Su Y.,Wang Y.,Liu H. .2015 .Pyruvate kinase, muscle isoform 2 promotes proliferation and insulin secretion of pancreatic β -cells via activating Wnt/CTNNB1 signaling. International Journal of Clinical and Experimental Pathology, 8(11) : 14441.
Zhong X.,Chung A. C. K.,Chen H. Y.,Dong Y.,Meng X. M.,Li R.,Lan H. Y. .2013 .miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. , 56 : 663-674.
Fryirs M. A.,Barter P. J.,Appavoo M.,Tuch B. E.,Tabet F.,Heather A. K.,Rye K. A. .2010 .Effects of high-density lipoproteins on pancreatic β -cell insulin secretion. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(8) : 1642-1648.
Song X.,Teng J.,Wang A.,Li X.,Wang J.,Liu Y. .2016 .Positive correlation between serum IGF-1 and HDL-C in type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 118 : 44-49.
Sun C.,Huang F.,Liu X.,Xiao X.,Yang M.,Hu G.,Liao L. .2015 .miR-21 regulates triglyceride and cholesterol metabolism in nonalcoholic fatty liver disease by targeting HMGCR. International Journal of Molecular Medicine, 35(3) : 847-853.
Meng F.,Henson R.,Wehbe-Janek H.,Ghoshal K.,Jacob S. T.,Patel T. .2007 .MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133(2) : 647-658.
Wu H.,Ng R.,Chen X.,Steer C. J.,Song G. .2016 .MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway. Gut, 65(11) : 1850-1860.
Calo N.,Ramadori P.,Sobolewski C.,Romero Y.,Maeder C.,Fournier M.,Foti M. .2016 .Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption. Gut, 65(11) : 1871-1881.
Gjorgjieva M.,Sobolewski C.,Dolicka M. C.,Foti M. .2019 .miRNAs and NAFLD: from pathophysiology to therapy. Gut, 68(11) : 2065-2079.
Sala La,Cattaneo L.,De Nigris M.,Pujadas V.,Testa G.,Bonfigli R.,Ceriello A. R.,A. A. R. .2016 .Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells. Cardiovascular Diabetology, 15 : 1-9.
Leiter L. A.,Ceriello A.,Davidson J. A.,Hanefeld M.,Monnier L.,Owens D. R.,I. G. R. P. S. D. R. .2005 .Postprandial glucose regulation: New data andnew implications. Clinical therapeutics, 27 : S42-S56.
0

Citations

0

Downloads

73

Views